Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Respiratory function in amyotrophic lateral sclerosis.

J Iłzecka1, Z Stelmasiak, G Balicka

  • 1Department of Neurology, University School of Medicine, Jaczewskiego 8, 20-954 Lublin, Poland.

Neurological Sciences : Official Journal of the Italian Neurological Society and of the Italian Society of Clinical Neurophysiology
|December 6, 2003
PubMed
Summary

Amyotrophic lateral sclerosis (ALS) impacts respiratory function. Vital capacity (FVC) is higher in patients with limb onset compared to bulbar onset, regardless of disease duration.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Diagnostic value of plasma expression of microRNAs complementary to Drosha and Dicer in lung cancer patients.

European review for medical and pharmacological sciences·2019
Same author

Effect of carotid endarterectomy on brain damage markers.

Acta neurologica Scandinavica·2016
Same author

Paraoxonase 1 activity in multiple sclerosis patients during mitoxantrone therapy.

Acta neurologica Scandinavica·2012
Same author

EMMPRIN levels in serum of patients with amyotrophic lateral sclerosis.

Acta neurologica Scandinavica·2011
Same author

A randomized, double-blind, placebo-controlled, parallel-group, enriched-design study of nabiximols* (Sativex(®) ), as add-on therapy, in subjects with refractory spasticity caused by multiple sclerosis.

European journal of neurology·2011
Same author

Total tau and S100b proteins in different types of multiple sclerosis and during immunosuppressive treatment with mitoxantrone.

Acta neurologica Scandinavica·2010

Area of Science:

  • Neurology
  • Pulmonology
  • Clinical Medicine

Background:

  • Amyotrophic lateral sclerosis (ALS) is a progressive neurodegenerative disease.
  • Respiratory failure is the primary cause of mortality in ALS patients.
  • Understanding respiratory function in ALS is crucial for patient management.

Purpose of the Study:

  • To investigate the relationship between vital capacity (FVC) and forced expiratory volume in 1 second (FEV1) in ALS patients.
  • To determine if the site of ALS onset (limb vs. bulbar) affects respiratory function.
  • To assess the impact of disease duration on respiratory parameters in ALS.

Main Methods:

  • Retrospective analysis of 18 ALS patients.
  • Categorization of patients based on the site of ALS onset (limb or bulbar).

Related Experiment Videos

  • Division of patients into groups based on disease duration.

    • Main Results:

    • Vital capacity (FVC) was significantly higher in patients with limb onset compared to those with bulbar onset.
    • No significant difference in FVC was observed based on disease duration.
    • The study identified significant respiratory function disturbances in ALS patients.

    Conclusions:

    • The site of ALS onset is a significant factor influencing vital capacity (FVC).
    • Bulbar onset ALS is associated with lower FVC compared to limb onset ALS.
    • Respiratory function monitoring is essential in ALS management, with potential differences based on onset type.